What is the target international normalized ratio (INR) for patients taking warfarin?

Target INR for Patients on Warfarin

For most patients on warfarin, the target INR is 2.5 with a therapeutic range of 2.0–3.0. 1, 2, 3

Standard Therapeutic Ranges by Indication

Most Common Indications (Target INR 2.0–3.0)

• Atrial fibrillation requires an INR range of 2.0–3.0, with an optimal target of 2.5 1, 2, 3
• Venous thromboembolism (including deep vein thrombosis and pulmonary embolism) requires the same INR range of 2.0–3.0 1, 2
• Rheumatic heart disease and mitral valve disease require an INR target of 2.5 (range 2.0–3.0) 1
• Cardioversion in atrial fibrillation requires INR 2.0–3.0 1

Higher-Intensity Targets (INR 2.5–3.5)

• Mechanical heart valves require a higher target INR of 2.5–3.5, particularly for mitral position valves or older ball-cage models 1, 2, 3
• Patients at extremely high risk of stroke may require INR 2.5–3.5 1
• Bileaflet or tilting disc prosthetic valves typically require INR 2.5–3.5 2, 3

Special High-Risk Situations (INR 3.0–4.5)

• Mitral valve disease with prior embolic stroke may require an even higher target INR of 3.0–4.5 1
• Caged ball or caged disc valves require higher INR targets than modern prosthetic valves 2, 3

Understanding the Therapeutic Window

The risk of thromboembolism increases significantly when INR falls below 2.0, while bleeding risk rises exponentially when INR exceeds 3.0–3.5. 1, 3

• Subtherapeutic anticoagulation (INR <2.0) significantly increases the risk of thromboembolism 1
• Bleeding risk becomes clinically significant primarily when INR exceeds 5.0, after which it escalates exponentially 1, 4, 3
• The risk of intracranial hemorrhage increases sharply when INR rises above 3.5 1

Monitoring Schedule to Maintain Target INR

Initial Phase

• Check INR daily until the therapeutic range is reached and sustained for 2 consecutive days 1
• Then check 2–3 times weekly for 1–2 weeks 1
• Then check weekly for 1 month 1

Maintenance Phase

• Once stable, monitoring can be reduced to intervals as long as 4 weeks (and up to 12 weeks for patients with consistently stable values) 1
• More frequent monitoring is required during medication changes (especially antibiotics), dietary changes, weight fluctuations, illness, or any indication of bleeding 1

Special Population Considerations

Elderly Patients (>65 years)

• Elderly patients may require lower maintenance doses of warfarin (typically 2–4 mg daily rather than 5 mg) due to increased sensitivity 1
• They have higher bleeding risk at any given INR level 1, 4
• Some older guidelines suggested lower INR targets (1.5–2.5) for patients ≥75 years with atrial fibrillation, but current evidence does not support routine use of these lower targets 1

Patients with Mechanical Heart Valves

• Warfarin is the only recommended oral anticoagulant for mechanical heart valves; direct oral anticoagulants (DOACs) are contraindicated 5
• The specific target depends on valve type and position, ranging from 2.5–3.5 for most modern valves 1, 2

Common Pitfalls to Avoid

• Do not target INR ranges below 2.0 without strong evidence, as this may lead to inadequate protection against thromboembolism 1
• Inconsistent vitamin K intake through diet can cause fluctuations in INR values 1
• Avoid switching to DOACs in patients with moderate-to-severe mitral stenosis or mechanical heart valves, as warfarin remains the only appropriate anticoagulant 5
• Do not delay dose adjustments in high-risk indications requiring INR 2.5–3.5, as prolonged subtherapeutic INR significantly elevates thromboembolic risk 1